Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofluid Biopsies and Companion Diagnostics 2014

Oscar Puig's Biography



Oscar Puig, Biomarker Leader, Hoffmann La Roche

Oscar Puig is a Biomarker and Experimental Medicine Leader in Oncology at the Translational Clinical Research Center, Roche, where he joined in 2012. Prior to that, he was an Associate Director in the department of Informatics and Analysis, Merck Research Labs. He earned his Ph.D. at the University of Valencia, Spain, and carried out postdoctoral research at the European Molecular Biology Laboratory, in Heidelberg, Germany, and in the lab of Bob Tjian, at UC Berkeley, CA. Before joining Merck in 2006, he held an independent position as a group leader at the University of Helsinki, where he is a docent. Dr Puig has over 40 publications in peer-reviewed journals. His interest is the development and implementation of biomarkers in Clinical Oncology.

Oscar Puig Image

From Biomarkers to Diagnostics: Personalized Medicine in Hepatocellular Carcinoma

Monday, 27 October 2014 at 11:00

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com

The development of personalized therapies for hepatocellular carcinoma (HCC) has been challenging because of the complexity and heterogeneity of this disease. We will present the biomarker analysis of a global phase II clinical trial with an immunotherapy targeting glypican-3, a well-known prognostic factor in HCC. Our research identified a potential biomarker that could be used to select patients benefiting from this therapy. We will show analyses results as well as assay development process leading to biomarker validation.


Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonBiofluid Biopsies and Companion Diagnostics 2014Biofluid Biopsies and Companion Diagnostics 2014 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com